Skip to main content
All lobbying clients

SOLENO THERAPEUTICS, INC.

Lobbying client · California · filed 2025 to 2026

Soleno is focused on development of novel therapeutics for treatment of rare diseases.

$460,000 Reported spend
11 Filings counted
1 Outside firm hired
18 Bills named

Spend is reported income plus in-house expenses across 11 filings. 1 further filing for this client was restated by a later amendment and is left out of every total here. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 2 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well.

 Who filed for this client 2

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 18
  • H.R. 1414
    Cameron’s Law
    9 filings
  • H.R. 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…
    8 filings
  • S. 832
    EPIC Act of 2025
    8 filings
  • H.R. 7118
    Genomic Answers for Children’s Health Act of 2026
    5 filings
  • H.R. 1262
    Mikaela Naylon Give Kids a Chance Act
    4 filings
  • H.R. 1509
    Accelerating Kids’ Access to Care Act of 2025
    4 filings
  • H.R. 946
    ORPHAN Cures Act
    4 filings
  • S. 752
    Accelerating Kids’ Access to Care Act
    4 filings
  • S. 932
    Give Kids a Chance Act of 2025
    4 filings
  • H.R. 2450
    Prescription Drug Transparency and Affordability Act
    2 filings
  • H.R. 5509
    Safe Step Act
    2 filings
  • H.R. 6423
    HELP Copays Act
    2 filings
  • S. 2903
    Safe Step Act
    2 filings
  • S. 526
    Pharmacy Benefit Manager Transparency Act of 2025
    2 filings
  • S. 527
    Prescription Pricing for the People Act of 2025
    2 filings
  • S. 864
    HELP Copays Act
    2 filings
  • S. 882
    Patients Before Middlemen Act
    2 filings
  • S. 3019
    No Big Blockbuster Bailouts Act
    1 filing
 Reported by year 2 years
  • 2026 $260,000 7 filings
  • 2025 $200,000 4 filings
 Issues lobbied 7

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 2
  • HOUSE OF REPRESENTATIVES 10
  • SENATE 10
 Recent filings 12 total
Q3 termination
THE KPM GROUP DC LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $10,000 income · posted Oct 20, 2026
View →
Q3 termination
SOLENO THERAPEUTICS, INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $70,000 expenses · posted Sep 29, 2026
View →
Q2 amendment
THE KPM GROUP DC LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $10,000 income · posted Jul 28, 2026
View →
Q2 report
SOLENO THERAPEUTICS, INC.
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $70,000 expenses · posted Jul 20, 2026
View →
Q2 reportNo activity
THE KPM GROUP DC LLC Amended
2nd Quarter 2026 (Apr 1 - June 30) · $10,000 income · posted Jul 19, 2026
View →
Q1 report
SOLENO THERAPEUTICS, INC.
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $80,000 expenses · posted May 8, 2026
View →
Registration
SOLENO THERAPEUTICS, INC.
1st Quarter 2026 (Jan 1 - Mar 31) · posted May 4, 2026
View →
Q1 report
THE KPM GROUP DC LLC
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $20,000 income · posted Apr 20, 2026
View →
Q4 report
THE KPM GROUP DC LLC
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $50,000 income · posted Jan 14, 2026
View →
Q3 report
THE KPM GROUP DC LLC
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 13, 2025
View →
Q2 report
THE KPM GROUP DC LLC
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 17, 2025
View →
Q1 report
THE KPM GROUP DC LLC
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $50,000 income · posted Apr 21, 2025
View →

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem